By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences today reported a 43 percent drop in its third quarter revenues.

In a document filed with the US Securities and Exchange Commission, the sequencing technology and diagnostics firm reported that for the three months ended Sept. 30, it recorded $636,000 in revenues, down from $1.1 million in the year-ago period. Product revenues plummeted to $214,000 from $1.1 million, an 81 percent drop-off. Grant revenues rose to $422,000 from $13,000 a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.